Skylands Capital LLC Has $3.97 Million Stock Holdings in Haemonetics Corporation $HAE
Skylands Capital LLC grew its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 195.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 81,369 shares...
MarketBeat·1d ago
More News
Haemonetics (HAE) International Revenue Performance Explored
Evaluate Haemonetics' (HAE) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Zacks·2d ago
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·3d ago
Haemonetics Q3 Earnings Call Highlights
Haemonetics (NYSE:HAE) management struck an upbeat tone on its fiscal third-quarter 2026 earnings call, highlighting outsized growth in its NexSys plasma platform and TEG hospital blood management...
MarketBeat·6d ago
Haemonetics (NYSE:HAE) Trading Down 5.6% - Here's What Happened
Haemonetics (NYSE:HAE) Stock Price Down 5.6% - Here's Why...
MarketBeat·6d ago
These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings
read more...
Benzinga·6d ago
Haemonetics (HAE) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HAE beats Q3 EPS and revenue estimates as margins expand sharply, but sales fall 2.7% year over year, sending shares down after the report.
Zacks·6d ago
Haemonetics' (HAE) "Buy" Rating Reaffirmed at BTIG Research
BTIG Research reiterated a "buy" rating and issued a $88.00 price objective on shares of Haemonetics in a research note on Friday...
MarketBeat·6d ago
Haemonetics (NYSE:HAE) Announces Earnings Results, Beats Estimates By $0.04 EPS
Haemonetics (NYSE:HAE - Get Free Report) posted its quarterly earnings results on Thursday. The medical instruments supplier reported $1.31 earnings per share (EPS) for the quarter, topping analysts...